Interventions for improving glycemic control in type 2 diabetic patients

dc.contributor.author	Βλάχου, Ευγενία Δ.	el
dc.contributor.author	Βαρδάκη, Ζαμπία	el
dc.contributor.author	Γκοβίνα, Ουρανία	el
dc.contributor.author	Καυγά-Παλτόγλου, Άννα	el
dc.contributor.author	Κουτσοπούλου - Σοφικίτη, Βασιλική	el
dc.date.accessioned	2015-04-28T14:48:37Z
dc.date.available	2015-04-28T14:48:37Z
dc.date.issued	2015-04-28
dc.identifier.uri	http://hdl.handle.net/11400/9168
dc.rights	Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.source	http://hsj.gr	el
dc.subject	Διαβήτη τύπου 2
dc.subject	Αντιδιαβητικά φάρμακα
dc.subject	Μονοθεραπεία
dc.subject	Type 2 diabetes
dc.subject	Antidiabetic drugs
dc.subject	Monotherapy
dc.title	Interventions for improving glycemic control in type 2 diabetic patients	en
heal.type	journalArticle
heal.classification	Ιατρική
heal.classification	Νοσηλευτική
heal.classification	Medicine
heal.classification	Nursing
heal.classificationURI	N/A-Ιατρική
heal.classificationURI	N/A-Νοσηλευτική
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI	http://id.loc.gov/authorities/subjects/sh85093362
heal.contributorName	Κελέση-Σταυροπούλου, Μάρθα Ν.	el
heal.language	en
heal.access	free
heal.publicationDate	2011
heal.bibliographicCitation	Vlachou, E., Vardaki, Z., Govina, U., Kavga-Paltoglou, A., Kutsopoulou-Sofikiti, V., et. al. (2011) Interventions for improving glycemic control in type 2 diabetic patients. "Health Science Journal". [online] 5(1), pp.60-65. Available from: http://hsj.gr [Accessed 28/04/2015].	en
heal.abstract	Background: Type 2 diabetes mellitus is a progressive disease with deterioration of glycemic control over time. The nursing community, nowadays, is well aware of the increasing frequency and health cost burden of the diabetic complications. Monotherapeutic attempts often fail in the long run. We examined the effect of adding rosiglitazone to glimepiride treatment on glycemic control in patients with type 2 diabetes mellitus when compared with increasing the glimepiride dose. The aim of the study was to show that adding a second antidiabetic agent, with a different mode of action but complementary to the one the patient is using, we can achieve better glycemic control than by increasing the dose of the first antidiabetic agent. Material and Method: 286 inadequately controlled Greek patients with diabetes mellitus type 2, were enrolled in the study. All patients were receiving glimepiride 4mg once daily. In the first group the patients were given rosiglitazone in addition to glimepiride. In the second group the dose of glimepiride was increased.	en
heal.publisher	Κυρίτση – Κουκουλάρη Ελένη	el
heal.journalName	Health Science Journal	en
heal.journalType	peer-reviewed
heal.fullTextAvailability	true